Literature DB >> 11245426

Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.

M Sanchez-Cespedes1, S A Ahrendt, S Piantadosi, R Rosell, M Monzo, L Wu, W H Westra, S C Yang, J Jen, D Sidransky.   

Abstract

The etiology of lung tumors arising in nonsmokers remains unclear. Although mutations in the K-ras and p53 genes have been reported to be significantly higher in smoking-related lung carcinomas, in the present study we performed a more comprehensive analysis in search of additional genetic changes between lung adenocarcinoma from tobacco- and non-tobacco-exposed patients. We selected a matched cohort of 18 lifetime nonsmoking and 27 smoking patients diagnosed with primary adenocarcinoma of the lung and searched for chromosomal alterations in each tumor by testing normal and tumor tissue with 54 highly polymorphic microsatellite markers located on 28 different chromosomal arms. Allelic losses or gains at chromosomal arms 3p (37 versus 6%), 6q (46 versus 12%), 9p (65 versus 22%), 16p (28 versus 0%), 17p (45 versus 11%), and 19p (58 versus 16%) were present significantly more often in adenocarcinomas from smokers than from nonsmokers. Chromosomal arms showing allelic imbalance in lung tumors from nonsmokers were rare but occurred more often at 19q (22%), 12p (22%), and 9p (22%). The FAL (fractional allelic loss or gain) is defined as the percentage of chromosomal arm losses/gains among the total informative chromosomal arms. Tumors from smokers harbored higher levels of FAL (13 (48%) of 27 showed FAL > or = 0.3) compared with the lung tumors from the nonsmoker patients (2 (11%) of 18 showed FAL > or = 0.3; P = 0.02; odds ratio, 0.13; 95% confidence interval, 0.01-0.79). Our data demonstrate that widespread chromosomal abnormalities are frequent in lung adenocarcinoma from smokers, whereas these abnormalities are infrequent in such tumors arising in nonsmokers. These observations support the notion that lung cancers in nonsmokers arise through genetic alterations distinct from the common events observed in tumors from smokers.

Entities:  

Mesh:

Year:  2001        PMID: 11245426

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

2.  SIFORM: shared informative factor models for integration of multi-platform bioinformatic data.

Authors:  Xuebei An; Jianhua Hu; Kim-Anh Do
Journal:  Bioinformatics       Date:  2016-07-05       Impact factor: 6.937

Review 3.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

4.  Lung cancers unrelated to smoking: characterized by single oncogene addiction?

Authors:  Kenichi Suda; Kenji Tomizawa; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  Int J Clin Oncol       Date:  2011-06-08       Impact factor: 3.402

5.  Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer.

Authors:  R K Gill; S-H Yang; D Meerzaman; L E Mechanic; E D Bowman; H-S Jeon; S Roy Chowdhuri; A Shakoori; T Dracheva; K-M Hong; J Fukuoka; J-H Zhang; C C Harris; J Jen
Journal:  Oncogene       Date:  2011-05-02       Impact factor: 9.867

6.  Prevalence and specificity of LKB1 genetic alterations in lung cancers.

Authors:  S Matsumoto; R Iwakawa; K Takahashi; T Kohno; Y Nakanishi; Y Matsuno; K Suzuki; M Nakamoto; E Shimizu; J D Minna; J Yokota
Journal:  Oncogene       Date:  2007-03-26       Impact factor: 9.867

7.  DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.

Authors:  Qinghua Feng; Stephen E Hawes; Joshua E Stern; Linda Wiens; Hiep Lu; Zhao Ming Dong; C Diana Jordan; Nancy B Kiviat; Hubert Vesselle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

8.  Genomic aberrations in lung adenocarcinoma in never smokers.

Authors:  Bastien Job; Alain Bernheim; Michèle Beau-Faller; Sophie Camilleri-Broët; Philippe Girard; Paul Hofman; Julien Mazières; Saloua Toujani; Ludovic Lacroix; Julien Laffaire; Philippe Dessen; Pierre Fouret
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

9.  Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.

Authors:  Tasneem Motiwala; Kalpana Ghoshal; Anindita Das; Sarmila Majumder; Dieter Weichenhan; Yue-Zhong Wu; Kristen Holman; S Jill James; Samson T Jacob; Christoph Plass
Journal:  Oncogene       Date:  2003-09-25       Impact factor: 9.867

10.  Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers.

Authors:  Xifeng Wu; Liang Wang; Yuanqing Ye; Jeremiah A Aakre; Xia Pu; Gee-Chen Chang; Pan-Chyr Yang; Jack A Roth; Randolph S Marks; Scott M Lippman; Joe Y Chang; Charles Lu; Claude Deschamps; Wu-Chou Su; Wen-Chang Wang; Ming-Shyan Huang; David W Chang; Yan Li; V Shane Pankratz; John D Minna; Waun Ki Hong; Michelle A T Hildebrandt; Chao Agnes Hsiung; Ping Yang
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.